Successful sale of MTR to SHS
Successful sale of Medizintechnik Rostock to SHS Capital: DZ BANK advises the owners in a competitive international bidding process die Eigentümer im Rahmen eines kompetitiven, internationalen Bieterverfahrens
DZ BANK advises the shareholders of Medizintechnik Rostock on the sale of a majority stake to SHS Capital
Medizintechnik Rostock (MTR), founded in 1994, specializes in the distribution of medical technology aids. The focus of the Berlin-based home care provider is on the distribution of devices in the segments of movement therapy, electro therapy and compression therapy, as well as the proper instruction of patients. The medical technology company has signed contracts with all relevant health insurance providers and, over the course of its 30-year history, has established itself in all federal states.
SHS Capital, headquartered in Tübingen, Germany, is an investment company with an explicit focus on the healthcare industry. In the past, the private equity investor has repeatedly and successfully supported the growth of companies in several fund generations, including home care specialist medigroba in the run-up to its sale to the Löwenstein Group.
The transaction opens up specific growth opportunities that will enable MTR to benefit from the SHS Capital network and, if intended, serve as a platform for add-on acquisitions in the distribution of medical aids.
Responsible on the side of DZ BANK were Dr. Wolfgang Wybranietz, Dr. Georgi Bontschev, Jan Säcker and Sebastian Korz.
